SCHEMBL8787207

SCHEMBL8787207

CNC(=O)Oc1c(CO)no[n+]1[O-]

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
PTPN7 P35236 1/20 0.31
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9268626 0.87 GLA (0.33) GLALMNA
SCHEMBL8785818 0.84 GLA (0.38) GLASMN1; SMN2RAB9AALDH1A1LMNA
SCHEMBL8785463 0.84 LMNA (0.36) GLASMN1; SMN2ALDH1A1LMNATP53
SCHEMBL8786314 0.82 HPGD (0.32) GLASMN1; SMN2RAB9AHPGD
SCHEMBL8786116 0.82 ALDH1A1 (0.36) GLASMN1; SMN2RAB9AALDH1A1LMNA
SCHEMBL8785232 0.80 CA12 (0.37) GLASMN1; SMN2RAB9AALDH1A1LMNA
SCHEMBL8785677 0.79 GLA (0.39) GLASMN1; SMN2RAB9AALDH1A1LMNA
SCHEMBL8785363 0.79 RAB9A (0.33) GLASMN1; SMN2RAB9AALDH1A1LMNA
SCHEMBL8786073 0.76 KMT2A (0.42) SMN1; SMN2RAB9AALDH1A1LMNAHPGD
SCHEMBL8786389 0.76 GLA (0.37) GLAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0687256-B1 HYDROXYMETHYL FURAZANE CARBOXYLIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF CARDIO-VASCULAR CONDITIONS HOECHST AG (DE) 1997-09-03 EP disclosed